About OXB OXB (LSE: OXB) is a global quality and innovation-led contract development and manufacturing organisation (CDMO) in cell and gene therapy with a mission to enable its clients to deliver life ...
Opportunities in viral vector manufacturing arise from rising demand for GMP-grade materials and increasing gene therapy ...
OXB to participate in upcoming investor conferences and events Oxford, UK – 27 October 2025: OXB (LSE: OXB), a global quality and innovation-led ...
Sarepta Therapeutics Inc. (NASDAQ:SRPT) is one of the best mid cap growth stocks to invest in now. Earlier on June 4, Sarepta Therapeutics announced that the US FDA has granted Platform Technology ...
The signing took place at KFSHRC's pavilion during the Global Health Exhibition 2025, with signatories: Dr. Majid Alfayyadh, ...
Medpage Today on MSNOpinion
Expert Warns of Irreparable Damage to Biotech Industry Unless Congress Acts
Sen. Bill Cassidy, MD (R-La.), chair of the committee, applauded medical innovations of the last few decades including ...
Oxford BioMedica ( ($GB:OXB) ) has shared an announcement. Oxford Biomedica (OXB) has been recognized as a Champion in the ‘Cell & Gene Therapy’ ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback